A study of respiratory patients across urban India has identified winter as the most dangerous season for people with lung disease, with the period accounting for nearly a third of respiratory hospitalisations and deaths recorded in the research. The finding is important not only as a seasonal health warning but also as a reminder that urban respiratory risk is shaped by a combination of outdoor pollution, indoor exposure, infections, chronic illness and the ability of hospitals to absorb sudden demand.
The study, published in the journal Lung India, draws on the Seasonal Waves of Respiratory Disorders survey, conducted across 245 medical centres in different parts of the country. The research included about 17 centres in Mumbai, the Mumbai Metropolitan Region and Navi Mumbai. It tracked nearly 2,900 hospitalisations across four seasonal weeks in summer, monsoon and winter during 2017-2018, and analysed 394 deaths.
The period covered by the survey is significant. The study does not present a live national surveillance system or establish that the same proportions apply unchanged today. Its lead author, Sheetu Singh of the department of pulmonary medicine at Rajasthan Hospital in Jaipur, said the research had established a trend but that larger studies would be needed to determine the causes. The evidence therefore points to a recurring seasonal pattern while leaving the precise contribution of individual risk factors open.
That distinction matters for cities. A seasonal increase in respiratory emergencies is not created by one pollutant, one infection or one category of patient. It reflects the interaction between the urban environment and the health vulnerabilities of residents. The study identifies chronic obstructive pulmonary disease, or COPD, as the leading cause of mortality among the cases examined, followed closely by respiratory tract infections. It also records exposure to biomass fuel, smoking, mould and, in cases of interstitial lung disease, pets or birds at home as relevant risk factors.
These exposures connect respiratory health to the design and management of everyday urban spaces. Housing conditions determine whether dampness and mould persist indoors. Cooking arrangements influence exposure to smoke and biomass fuel. Ventilation affects how pollutants and infectious particles circulate. At the neighbourhood level, traffic, construction activity and other pollution sources shape the air residents breathe outside their homes. The supplied study does not quantify the contribution of each of these factors, but its list of risks shows why winter mortality cannot be understood through hospital treatment alone.
The study also points to the way seasonal risks change rather than simply rise and fall. Dr Sundeep Salvi, a pulmonologist at the Pulmocare Research and Education Foundation in Pune and one of the study’s authors, said summer was now considered safer for lung patients, while pollution had a direct correlation with high mortality in winter and viral infections were more significant during the monsoon. This division does not mean that one season is safe for every patient. It indicates that different seasonal conditions may push vulnerable people into hospital through different pathways.
The monsoon finding is particularly relevant to the question of how urban health systems plan for demand. The study reported that more lung cancer cases were recorded during the monsoon, but the researchers said this required validation in larger prospective datasets to establish whether it represented a genuine seasonal pattern or a chance finding. That caution is central to interpreting the research. A reported pattern is not automatically a proven causal relationship, especially when the study covers selected seasonal weeks rather than continuous monitoring across several years.
The clearer signal in the research concerns respiratory tract infections. Winter accounted for nearly 45% of all respiratory-tract-infection-related deaths recorded in the study. Dr Pralhad Prabhudesai, a Mumbai-based pulmonologist who contributed case studies to the paper, said doctors had long observed that serious cases increase when weather patterns change. He described a progression in which routine clinic visits for minor infections peak during the monsoon, particularly among younger people, and can develop into emergencies during winter among older patients.
This progression reveals a gap between the way respiratory disease is experienced and the way it is often counted. The most visible event is the hospital admission or death. Before that point, however, there may be repeated outpatient visits, delayed treatment, deteriorating symptoms, household exposure and limited capacity to manage chronic disease. The study does not provide a full account of these stages, but the seasonal pattern it records suggests that winter hospital demand is the endpoint of pressures that build across homes, neighbourhoods and primary-care services.
The patient profile in the survey also raises questions about how respiratory protection is targeted. Men represented 64.3% of hospitalised patients and 69% of respiratory deaths, compared with 35.7% of hospitalised patients who were women. Those figures describe the study population; they do not by themselves establish that men face greater biological risk. Differences in smoking, occupational exposure, healthcare access, diagnosis and other unmeasured factors could influence the distribution. The available material does not provide enough evidence to separate these explanations.
The presence of comorbidities further complicates the urban health picture. Smoking, diabetes mellitus, gastro-oesophageal reflux disease, hypertension, coronary artery disease and anaemia were identified as conditions associated with higher mortality risk. For city health systems, this means that respiratory preparedness cannot be isolated from chronic-disease management. A patient with COPD may also require care for cardiovascular disease or diabetes, and deterioration during a seasonal stress period can place pressure on multiple parts of the health system at once.
The institutional responsibility is therefore distributed. Hospitals handle acute admissions and deaths, while pulmonologists and other clinicians identify clinical risk. Public-health agencies are responsible for surveillance and communication. Municipal systems influence the environmental conditions in which people live, including waste, drainage and the maintenance of public spaces, even though the supplied study does not measure these municipal functions directly. Housing providers, workplaces and households also shape exposure to smoke, mould, dust and other risks.
Pollution is another area where the study’s findings have implications but not a complete explanation. Dr Salvi’s comment links winter mortality to pollution, while the researchers’ broader findings identify several additional exposures and comorbidities. The research reported in the supplied material does not provide city-level pollution measurements, pollutant concentrations or a comparison between Mumbai and other urban centres. It therefore cannot establish how much of the winter pattern is attributable to outdoor air pollution in any particular city.
That limitation does not make the urban connection marginal. Winter conditions can bring together several vulnerabilities at the same time: chronic lung disease, respiratory infections, exposure to polluted air and delayed escalation of symptoms. The research indicates that these pressures are visible in hospitals across a geographically diverse network of centres. It does not show that every city experiences the same pattern or that every winter produces the same level of risk. More detailed local surveillance would be required for that conclusion.
The study’s age is another reason for careful use. Its patient data come from 2017-2018, while the report was published in 2026. The data remain relevant as evidence of a seasonal trend, but they should not be treated as a current estimate of hospitalisations or deaths. Singh’s call for larger studies and the researchers’ request for validation of the lung-cancer finding underline the need for updated, prospective data. Without that evidence, policymakers cannot reliably determine whether the proportions have changed or whether particular cities, age groups or exposure categories are driving current risk.
What the evidence does establish is a strong case for treating respiratory disease as an urban systems issue rather than a problem confined to specialist hospitals. Winter is associated with the highest burden in the study, COPD is the leading mortality category, respiratory infections are a major pathway, and household and behavioural exposures overlap with chronic conditions. The findings also show that the people most at risk are not limited to one age group: Prabhudesai said young lung patients had also died after symptoms worsened in winter.
The larger urban question is whether cities can identify respiratory risk before it becomes an emergency admission. The supplied study does not evaluate prevention programmes, municipal responses or hospital capacity, so it cannot answer that question directly. It does, however, provide a framework for examining them. Any response would need to connect seasonal disease surveillance with air-quality information, primary care, chronic-disease follow-up, housing conditions and clear clinical escalation pathways.
For now, the evidence supports a cautious but consequential conclusion. Winter represents the most dangerous seasonal period for lung disease patients in the study of urban India, but the causes are multiple and the available data do not establish the precise weight of each one. The next necessary evidence is larger, prospective and city-specific: research that can test the seasonal pattern, distinguish pollution from infection and other exposures, and show how hospital demand changes across different urban populations.
